2016 Programs & Information

Similar documents
Social Security Disability Insurance and young onset dementia: A guide for employers and employees

Lewy body dementia Referral for a Diagnosis

J/601/2874. This unit must be assessed in accordance with Skills for Care and Development s QCF Assessment Principles.

Dementia with Lewy bodies

What Is Dementia? Type of Dementia

Alzheimer s and memory loss

Alzheimer s and. memory loss

Objectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease.

Progression EARLY STAGE. What is Alzheimer s disease? The early stage - what to expect

How to identify, approach and assist employees with young onset dementia: A guide for employers

Communication Strategies for Primary Progressive Aphasia & FTD s:

Intellectual Symptoms Amnesia: Loss of memory function

Patients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault

CRITERIA FOR AD DEMENTIA June 11, 2010

What is vascular dementia?

1: Motor neurone disease (MND)

2014 Alzheimer s Disease Facts and Figures

10 warning signs of Alzheimer s disease

How To Write Long Term Care Insurance

An Introduction to Lewy Body Dementia

Traumatic brain injury (TBI)

10 steps to planning for Alzheimer s disease & other dementias A guide for family caregivers

Delirium. The signs of delirium are managed by treating the underlying cause of the medical condition causing the delirium.

The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia

UPDATES TO NEUROCOGNITIVE DISORDERS IN DSM-5 and DSM-5 DESK REFERENCE UPDATED

Progression MIDDLE STAGE. What is Alzheimer s disease?

Copywrite - Eric Freitag, Psy.D., 2012

Dementia Causes and Neuropsychological Evaluation of the Older Adult

Basics of Dementia Third Session: Progressive Memory Disorders (3rd edition, 3/27/07)

10 warning signs of alzheimer s disease

Chapter 4: Eligibility Categories

WHAT IS CEREBRAL PALSY?

NEUROIMAGING in Parkinsonian Syndromes

Johns Hopkins Memory & Alzheimer s Treatment Center

Current evidence suggests that Parkinson s tends to develop

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

Functions of the Brain

3030. Eligibility Criteria.

The Doctor Thinks It s FTD. Now What? A Guide for Managing a New Diagnosis

Parkinson's s disease - a

Alzheimer s disease. What is Alzheimer s disease?

PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS

basics of alzheimer s disease What it is and what you can do

Meeting the Needs of Aging Persons. Aging in Individuals with a

Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE

Alzheimer's: The Latest Assessment and Treatment Strategies

Continence in Dementia. Elizabeth Rand Manager, Cognitive Dementia & Memory Service (CDAMS) Caulfield Hospital

Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI)

2015 Alzheimer s Disease Facts and Figures

Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych.

Schizophrenia National Institute of Mental Health

What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician

Multiple System Atrophy guide (

Dementia & Movement Disorders

No Dementia Stage 2: Very Mild Cognitive Decline

MEMORY LOSS: WHAT IS NORMAL?

Understanding the Genetics of FTD

Bedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College

III./ Parkinsonian syndrome (parkinsonism, atypical parkinsonian disorders) in neurodegenerative diseases

Financial Advisors and Alzheimer s Disease: What You Need to Know

NEUROPSYCHOLOGY QUESTIONNAIRE. (Please fill this out prior to your appointment and bring it with you.) Name: Date of appointment: Home address:

Heads Up for Healthier Living

1 in 3 seniors dies with Alzheimer s or another dementia.

take care of yourself 10 ways to be a healthier caregiver

In conjunction with clinical history, structural

Cindy Mann, RN, BSN. Unit Manager. Centra Senior Psychiatric Program

Being an advocate for good care. Useful medications What to expect When to be concerned

PARKINSON S DISEASE INTRODUCTION. Parkinson s disease is defined as a disease of the nervous system that affects voluntary movement.

Alzheimer s disease. The importance of early diagnosis

Depression in Older Persons

Overview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013

PARTNERING WITH YOUR DOCTOR:

When it s time to apply for Social Security Disability Insurance: Making a stressful and complicated process easier for you and your family!

Parkinson s Disease (PD)

Color Vision Defects - Color Blindness

take care of yourself How to recognize and manage caregiver stress

Seizures explained. Helpline: Text: Epilepsy Scotland Guides

Learning Disabilities, Behavioral/Emotional Disorders, and Other Brain Disorders: What We Know

2016 ALZHEIMER S DISEASE FACTS AND FIGURES

How To Treat Aphasia

Everyone has mild memory lapses from time to time. You go

Donepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease

Parkinson s Disease Symptoms Guide

DISABILITY CLAIMS UNDER INSURANCE POLICIES

How To Navigate Early-Stage Alzheimer s Disease

Transcription:

Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia with Lewy Bodies Frontotemporal Dementia Corticobasal Degeneration Progressive Supranuclear Palsy Posterior Cortical Atrophy

This Catalog contains information on: Introduction to Mild Cognitive Impairment and Dementia: A definition of each disorder... 2 Dementia, Mild Cognitive Impairment, Alzheimer s disease, Dementia with Lewy Bodies, and Frontotemporal Lobar Degeneration including Frontotemporal Dementia and Primary Progressive Aphasia, Corticobasal Degeneration, Progressive Supranuclear Palsy, Behavioral Variant Frontotemporal Dementia, and Posterior Cortical Atrophy. Supportive Meetings... 4 Care Partner (Caregiver) Supportive Meetings are open to all persons who are caring for a person with Alzheimer s disease or other forms of dementia. Participants are welcome to attend one or both meetings each month Department of Neurology Family Seminar Days... 4 A full day comprehensive education seminar on dementia with Lewy bodies, frontotemporal dementia, primary progressive aphasia, corticobasal degeneration, progressive supranuclear palsy and posterior cortical atrophy Meeting of the Minds The Dementia Conference... 5 An annual conference that brings together national and local experts for a day of education, information, and support 24/7 Information Help-line... 5 A phone based service offering reliable information and support at any time to those who need assistance. Mayo Clinic Alzheimer s Disease Research Center... 5 Located in Rochester, MN and Jacksonville, FL, the research center conducts many types of research studies related to dementia, as well as normal or successful aging. 2

Introduction to Mild Cognitive Impairment and Dementia: Individuals who receive a diagnosis of mild cognitive impairment or early stage dementia often have questions, seek resources and support, and want to be an active participant in managing their condition. A diagnosis such as Alzheimer s disease, Dementia with Lewy Bodies, or Frontotemporal Lobar Degeneration affects more than just the person who has been diagnosed. In most cases, it also impacts family members and friends who become caregivers and advocates. Supportive meetings and programs such as the Family Seminar Days can help families and caregivers prepare, manage, and cope with this unanticipated role. It has been shown that participants in these types of programs tend to feel healthier and find caregiving more rewarding than those who do not. The best prescription for persons and families impacted by these disorders is the combination of medical treatment along with education, training and support. This catalog contains many opportunities for education, training, and support. Definitions and Symptoms Mild cognitive impairment is a transition stage between normal aging and the more serious problems of dementia caused by Alzheimer s disease and related conditions. The most common variety of mild cognitive impairment termed amnestic mild cognitive impairment - is associated with the tendency to forget upcoming appointments and details of recent events and conversations, and such individuals tend to repeat questions or statements. Many people with mild cognitive impairment eventually develop Alzheimer s disease, although some remain stable and others even return to normal. Those with other varieties of mild cognitive impairment tend to develop Dementia with Lewy Bodies, vascular dementia, or Frontotemporal Dementia. The core features of mild cognitive impairment are: Decline in one or more cognitive skills compared with other people of similar age and educational background. Some activities of daily living are compromised. Dementia refers to a set of symptoms, not the disease itself. These symptoms might include language difficulty, loss of recent memory or poor judgment. In other words, when an individual is said to have dementia, they are exhibiting certain symptoms that causes a loss of independence. With a thorough screening including blood tests, a mental status evaluation, neuropsychological testing, and a brain scan, doctors can accurately diagnose the cause of the dementia symptoms. Although Alzheimer s disease accounts for 60-70 percent of cases of dementia, other disorders that cause dementia include: vascular dementia, Parkinson s disease with dementia, Dementia with Lewy Bodies and Frontotemporal Degeneration. Alzheimer s disease is the most common cause of dementia, which is the loss of intellectual and social abilities severe enough to interfere with daily functioning. Dementia occurs in people with Alzheimer s disease because healthy brain tissue degenerates, causing a steady decline in memory and other mental abilities. Most people with Alzheimer s share certain signs and symptoms of the disease. These may include: Increasing and persistent forgetfulness Difficulties with abstract thinking Difficulty finding the right word Disorientation Loss of judgment Difficulty performing familiar tasks Personality changes Dementia with Lewy Bodies shares characteristics with both Alzheimer s disease and Parkinson s disease. Like Alzheimer s, it causes confusion. Like Parkinson s, it can result in rigid muscles, slowed movement and tremors. The most striking symptoms of Dementia with Lewy Bodies may be its visual hallucinations, which can be one of the first signs of the disorder. Dementia with Lewy Bodies signs and symptoms may include: Visual hallucinations Changes in movement similar to Parkinson s disease Delusions Confusion, memory loss, reduced attention span, vision/visuospatial problems Sleep difficulties and the tendency to seemingly act out one s dreams Frontotemporal Lobar Degeneration (FTLD) is an umbrella term for a diverse group of rare disorders that primarily affect the frontal and temporal lobes of the brain the areas generally associated with personality and behavior. Frontotemporal dementia tends to occur at a younger age than does Alzheimer s disease, typically between the ages of 40 and 70. Behavioral Variant Frontotemporal Dementia (bvftd) signs and symptoms include behavioral and personality changes such as: Increasingly inappropriate and disinhibited actions Loss of empathy, sympathy, and personal warmth toward others Lack of judgment and poor problem-solving abilities Apathy and lack of motivation to carry out usual daily activities Repetitive compulsive behavior A decline in personal hygiene Lack of awareness of thinking or behavioral changes Primary Progressive Aphasia (PPA) is characterized by an increasing difficulty in using and understanding written and spoken language. People with another subtype, semantic dementia, utter grammatically correct speech that has no relevance to the conversation at hand. Corticobasal degeneration (CBD) is a degenerative disorder of the brain in which nerve cells die over time, causing a progressive decline in the ability to move one or both sides of the body. Symptoms include arm or leg incoordination, arm or leg stiffness, tremor, gait unsteadiness, speech difficulty and problems with language (word finding, sentence structuring, comprehension, reading and writing). Progressive Supranuclear Palsy (PSP) is a degenerative disorder of the brain in which nerve cells die over time, causing a progressive decline in the ability to maintain balance and move the eyes. Symptoms include neck, arm or leg stiffness, gait unsteadiness, frequent falls, Parkinson s-like symptoms, and vision problems. Posterior Cortical Atrophy (PCA) is a cause of dementia with a main feature being progressive visual impairment in the absence of a clinically-diagnosed eye disease. Symptoms include visual field defects, inability to recognize people or objects, inability to see colors or draw objects, or cortical sensory loss. Some people may experience language dysfunction, limb apraxia, visual hallucinations, or parkinsonism. 2 3

Caregiver Meetings and Family Programs Supportive Meetings Care partner (caregiver) supportive meetings are open to all persons who are caring for a person with Alzheimer s disease or other forms of dementia. Participants are welcome to attend one or both meetings each month First Thursday of each month 1:30-3:00 p.m. Third Thursday of each month 5:00-6:30 p.m. Department of Neurology Seminars for Families Location: Alzheimer s Association Rochester Office 3224 6th Avenue NE Unit A Rochester MN (Across the street to the South from ShopKo North, next to Molly Maids) Contact: Debbie Richman Vice President Education and Outreach 952-830-0512 or drichman@alz.org Susan Siegle at 507-292-1170 or ssiegle@hcr-manorcare.com I am part of a supportive group of caregivers. Each of us understands the challenges of caring for someone with a dementia such as Alzheimer s disease. We gather each month to share experiences and receive support. We don t have all the answers, but we figure out how to break down difficult times into manageable moments. We listen to one another. ~ Participant Mayo Clinic Rochester Department of Neurology offers comprehensive educational seminars for Mayo Clinic patients and their families recently impacted by a diagnosis of Alzheimer s disease, Dementia with Lewy Bodies (DLB), Frontotemporal Dementia (FTD), Corticobasal Degeneration (CBD), Progressive Supranuclear Palsy (PSP), and Posterior Cortical Atrophy (PCA). The program provides families with information on disease symptoms and treatment, managing ongoing care, medical considerations and medication adjustments, psychosocial impact of caregiving and understanding resources. Participants receive information in a supportive setting with other families dealing with a similar diagnosis. Each seminar begins at 9:00 a.m. and ends at approximately 4:00 p.m. Persons diagnosed with the disease are welcome to attend. Please take into consideration the length of the day (7 hours) when deciding those best suited to attend. As space permits, care professionals may also register. 2016 Schedule: February 1 Frontotemporal Dementia (FTD) June 6 Dementia with Lewy Bodies (DLB) August 15 Corticobasal Degeneration (CBD) and Progressive Supranuclear Palsy (PSP) November 7 Posterior Cortical Atrophy (PCA) Time: 9:00 am.-4:00 p.m.. Cost: $50/person includes the program, a light breakfast, full lunch and materials. Contact: To register or for more information, call 507-284-1324. Location: Assisi Heights Conference Center 1001 14th St. NW Rochester MN Programs and Services for the Community Alzheimer s Caregiving E-Newsletter A bi-monthly newsletter featuring articles, expert advice, products and services on Alzheimer s disease or related dementia. To subscribe, please contact: mayoclinicalzheimers@everydayhealth.com Annual Conference Meeting of the Minds Dementia Conference March 19, 2016 The Meeting of the Minds: Dementia Conference 2015 is the premier dementia conference for persons with Mild Cognitive Impairment or early dementia, families, friends and professionals. The conference is a collaboration by the Alzheimer s Association Minnesota-North Dakota and Mayo Clinic, who work together to create a day designed to inform, equip and support persons with dementia, family caregivers and professionals. As in past years, national, regional and local presenters come together to ensure an innovative and insightful conference for the 1,300 participants and over 70 sponsors and exhibits. The historically sold-out conference will be held at the RiverCentre in St. Paul, Minnesota on Saturday, March 14, 2015. Learn more and register at www.alz.org/mnnd or call 800-272-3900. 24/7 Information Help-line The Alzheimer s Association offers a 24/7 Helpline that provides reliable information and support to all those who need assistance. Call toll-free anytime day or night at 1-800-272-3900. The 24/7 Helpline serves people with memory loss, caregivers, health care professionals and the public. Additional information on other programs and services offered by the Alzheimer s Association can be found at: www.alz.org/mnnd Mayo Clinic Alzheimer s Disease Research Center The Alzheimer s Disease Research Center and The Study of Aging at the Mayo Clinic conduct many types of research studies related to dementia, as well as normal or successful aging. The Mayo Clinic Alzheimer s Disease Research Center is currently one of 30 NIA (National Institute of Aging)-funded centers across the United States. At these centers, researchers work to translate research advances into improved care and diagnosis for patients with mild cognitive impairment, Alzheimer s disease, or a related dementia, while at the same time focusing on the program s long term goal finding a way to cure and possibly prevent Alzheimer s disease, Dementia with Lewy Bodies, Frontotemporal Lobar Degeneration, and related disorders. All research participation is an act of altruism and a gift to future generations. Ultimately thousands may benefit from the willingness of those who choose to become involved. Contact Us: Alzheimer s Disease Research Center Study of Aging Mayo Clinic 200 First Street SW Rochester, Minnesota 55905 507-284-1324 http://www.mayo.edu/research/centers-programs/ alzheimers-disease-research-center/overview 4 5

MC2815-04rev1115